English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 101 | Tables: 105 | Medical Care
The global market for Innovative Drug CRO (Contract Research Organisation) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Innovative Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Innovative Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Innovative Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Innovative Drug CRO (Contract Research Organisation) include Charles River, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv, ChemPartner, JOINN Lab, EVOTEC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Innovative Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Drug CRO (Contract Research Organisation).
The Innovative Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Innovative Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Innovative Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
IQVIA
Parexel
Syneos Health
MedPace
Wuxi AppTec
SUNNOVO
Pharmaron Beijing
Hangzhou Tigermed Consulting
Segment by Type
Clinical CRO
Preclinical CRO
Segment by Application
Pharmaceutical Companies
MAH Customer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Innovative Drug CRO (Contract Research Organisation) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical CRO
1.2.3 Preclinical CRO
1.3 Market by Application
1.3.1 Global Innovative Drug CRO (Contract Research Organisation) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 MAH Customer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Perspective (2020-2031)
2.2 Global Innovative Drug CRO (Contract Research Organisation) Growth Trends by Region
2.2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Region (2020-2025)
2.2.3 Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031)
2.3 Innovative Drug CRO (Contract Research Organisation) Market Dynamics
2.3.1 Innovative Drug CRO (Contract Research Organisation) Industry Trends
2.3.2 Innovative Drug CRO (Contract Research Organisation) Market Drivers
2.3.3 Innovative Drug CRO (Contract Research Organisation) Market Challenges
2.3.4 Innovative Drug CRO (Contract Research Organisation) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Innovative Drug CRO (Contract Research Organisation) Players by Revenue
3.1.1 Global Top Innovative Drug CRO (Contract Research Organisation) Players by Revenue (2020-2025)
3.1.2 Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Players (2020-2025)
3.2 Global Innovative Drug CRO (Contract Research Organisation) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Innovative Drug CRO (Contract Research Organisation) Revenue
3.4 Global Innovative Drug CRO (Contract Research Organisation) Market Concentration Ratio
3.4.1 Global Innovative Drug CRO (Contract Research Organisation) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Drug CRO (Contract Research Organisation) Revenue in 2024
3.5 Global Key Players of Innovative Drug CRO (Contract Research Organisation) Head office and Area Served
3.6 Global Key Players of Innovative Drug CRO (Contract Research Organisation), Product and Application
3.7 Global Key Players of Innovative Drug CRO (Contract Research Organisation), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Drug CRO (Contract Research Organisation) Breakdown Data by Type
4.1 Global Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Type (2020-2025)
4.2 Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031)
5 Innovative Drug CRO (Contract Research Organisation) Breakdown Data by Application
5.1 Global Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Application (2020-2025)
5.2 Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
6.2 North America Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
6.4 North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
7.2 Europe Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
7.4 Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
8.2 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025)
8.4 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
9.2 Latin America Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
9.4 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
10.2 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
10.4 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Innovative Drug CRO (Contract Research Organisation) Introduction
11.1.4 Charles River Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Innovative Drug CRO (Contract Research Organisation) Introduction
11.2.4 Labcorp Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Innovative Drug CRO (Contract Research Organisation) Introduction
11.3.4 Eurofins Scientific Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Innovative Drug CRO (Contract Research Organisation) Introduction
11.4.4 PPD Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.4.5 PPD Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Details
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Innovative Drug CRO (Contract Research Organisation) Introduction
11.5.4 ICON Plc Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.5.5 ICON Plc Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Details
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Innovative Drug CRO (Contract Research Organisation) Introduction
11.6.4 Pharmaron Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.6.5 Pharmaron Recent Development
11.7 Inotiv
11.7.1 Inotiv Company Details
11.7.2 Inotiv Business Overview
11.7.3 Inotiv Innovative Drug CRO (Contract Research Organisation) Introduction
11.7.4 Inotiv Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.7.5 Inotiv Recent Development
11.8 ChemPartner
11.8.1 ChemPartner Company Details
11.8.2 ChemPartner Business Overview
11.8.3 ChemPartner Innovative Drug CRO (Contract Research Organisation) Introduction
11.8.4 ChemPartner Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.8.5 ChemPartner Recent Development
11.9 JOINN Lab
11.9.1 JOINN Lab Company Details
11.9.2 JOINN Lab Business Overview
11.9.3 JOINN Lab Innovative Drug CRO (Contract Research Organisation) Introduction
11.9.4 JOINN Lab Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.9.5 JOINN Lab Recent Development
11.10 EVOTEC
11.10.1 EVOTEC Company Details
11.10.2 EVOTEC Business Overview
11.10.3 EVOTEC Innovative Drug CRO (Contract Research Organisation) Introduction
11.10.4 EVOTEC Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.10.5 EVOTEC Recent Development
11.11 Medicilon
11.11.1 Medicilon Company Details
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Innovative Drug CRO (Contract Research Organisation) Introduction
11.11.4 Medicilon Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.11.5 Medicilon Recent Development
11.12 Crown Bioscience
11.12.1 Crown Bioscience Company Details
11.12.2 Crown Bioscience Business Overview
11.12.3 Crown Bioscience Innovative Drug CRO (Contract Research Organisation) Introduction
11.12.4 Crown Bioscience Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.12.5 Crown Bioscience Recent Development
11.13 Champion Oncology
11.13.1 Champion Oncology Company Details
11.13.2 Champion Oncology Business Overview
11.13.3 Champion Oncology Innovative Drug CRO (Contract Research Organisation) Introduction
11.13.4 Champion Oncology Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.13.5 Champion Oncology Recent Development
11.14 IQVIA
11.14.1 IQVIA Company Details
11.14.2 IQVIA Business Overview
11.14.3 IQVIA Innovative Drug CRO (Contract Research Organisation) Introduction
11.14.4 IQVIA Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.14.5 IQVIA Recent Development
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Innovative Drug CRO (Contract Research Organisation) Introduction
11.15.4 Parexel Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.15.5 Parexel Recent Development
11.16 Syneos Health
11.16.1 Syneos Health Company Details
11.16.2 Syneos Health Business Overview
11.16.3 Syneos Health Innovative Drug CRO (Contract Research Organisation) Introduction
11.16.4 Syneos Health Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.16.5 Syneos Health Recent Development
11.17 MedPace
11.17.1 MedPace Company Details
11.17.2 MedPace Business Overview
11.17.3 MedPace Innovative Drug CRO (Contract Research Organisation) Introduction
11.17.4 MedPace Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.17.5 MedPace Recent Development
11.18 Wuxi AppTec
11.18.1 Wuxi AppTec Company Details
11.18.2 Wuxi AppTec Business Overview
11.18.3 Wuxi AppTec Innovative Drug CRO (Contract Research Organisation) Introduction
11.18.4 Wuxi AppTec Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.18.5 Wuxi AppTec Recent Development
11.19 SUNNOVO
11.19.1 SUNNOVO Company Details
11.19.2 SUNNOVO Business Overview
11.19.3 SUNNOVO Innovative Drug CRO (Contract Research Organisation) Introduction
11.19.4 SUNNOVO Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.19.5 SUNNOVO Recent Development
11.20 Pharmaron Beijing
11.20.1 Pharmaron Beijing Company Details
11.20.2 Pharmaron Beijing Business Overview
11.20.3 Pharmaron Beijing Innovative Drug CRO (Contract Research Organisation) Introduction
11.20.4 Pharmaron Beijing Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.20.5 Pharmaron Beijing Recent Development
11.21 Hangzhou Tigermed Consulting
11.21.1 Hangzhou Tigermed Consulting Company Details
11.21.2 Hangzhou Tigermed Consulting Business Overview
11.21.3 Hangzhou Tigermed Consulting Innovative Drug CRO (Contract Research Organisation) Introduction
11.21.4 Hangzhou Tigermed Consulting Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.21.5 Hangzhou Tigermed Consulting Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Clinical CRO
Table 3. Key Players of Preclinical CRO
Table 4. Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2020-2025)
Table 8. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2026-2031)
Table 10. Innovative Drug CRO (Contract Research Organisation) Market Trends
Table 11. Innovative Drug CRO (Contract Research Organisation) Market Drivers
Table 12. Innovative Drug CRO (Contract Research Organisation) Market Challenges
Table 13. Innovative Drug CRO (Contract Research Organisation) Market Restraints
Table 14. Global Innovative Drug CRO (Contract Research Organisation) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Players (2020-2025)
Table 16. Global Top Innovative Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CRO (Contract Research Organisation) as of 2024)
Table 17. Ranking of Global Top Innovative Drug CRO (Contract Research Organisation) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Innovative Drug CRO (Contract Research Organisation) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Headquarters and Area Served
Table 20. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Product and Application
Table 21. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2020-2025)
Table 25. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2026-2031)
Table 27. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2020-2025)
Table 29. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2026-2031)
Table 31. North America Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Charles River Company Details
Table 47. Charles River Business Overview
Table 48. Charles River Innovative Drug CRO (Contract Research Organisation) Product
Table 49. Charles River Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Labcorp Company Details
Table 52. Labcorp Business Overview
Table 53. Labcorp Innovative Drug CRO (Contract Research Organisation) Product
Table 54. Labcorp Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. Eurofins Scientific Company Details
Table 57. Eurofins Scientific Business Overview
Table 58. Eurofins Scientific Innovative Drug CRO (Contract Research Organisation) Product
Table 59. Eurofins Scientific Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 60. Eurofins Scientific Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Innovative Drug CRO (Contract Research Organisation) Product
Table 64. PPD Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 65. PPD Recent Development
Table 66. ICON Plc Company Details
Table 67. ICON Plc Business Overview
Table 68. ICON Plc Innovative Drug CRO (Contract Research Organisation) Product
Table 69. ICON Plc Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 70. ICON Plc Recent Development
Table 71. Pharmaron Company Details
Table 72. Pharmaron Business Overview
Table 73. Pharmaron Innovative Drug CRO (Contract Research Organisation) Product
Table 74. Pharmaron Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 75. Pharmaron Recent Development
Table 76. Inotiv Company Details
Table 77. Inotiv Business Overview
Table 78. Inotiv Innovative Drug CRO (Contract Research Organisation) Product
Table 79. Inotiv Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 80. Inotiv Recent Development
Table 81. ChemPartner Company Details
Table 82. ChemPartner Business Overview
Table 83. ChemPartner Innovative Drug CRO (Contract Research Organisation) Product
Table 84. ChemPartner Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 85. ChemPartner Recent Development
Table 86. JOINN Lab Company Details
Table 87. JOINN Lab Business Overview
Table 88. JOINN Lab Innovative Drug CRO (Contract Research Organisation) Product
Table 89. JOINN Lab Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 90. JOINN Lab Recent Development
Table 91. EVOTEC Company Details
Table 92. EVOTEC Business Overview
Table 93. EVOTEC Innovative Drug CRO (Contract Research Organisation) Product
Table 94. EVOTEC Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 95. EVOTEC Recent Development
Table 96. Medicilon Company Details
Table 97. Medicilon Business Overview
Table 98. Medicilon Innovative Drug CRO (Contract Research Organisation) Product
Table 99. Medicilon Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 100. Medicilon Recent Development
Table 101. Crown Bioscience Company Details
Table 102. Crown Bioscience Business Overview
Table 103. Crown Bioscience Innovative Drug CRO (Contract Research Organisation) Product
Table 104. Crown Bioscience Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 105. Crown Bioscience Recent Development
Table 106. Champion Oncology Company Details
Table 107. Champion Oncology Business Overview
Table 108. Champion Oncology Innovative Drug CRO (Contract Research Organisation) Product
Table 109. Champion Oncology Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 110. Champion Oncology Recent Development
Table 111. IQVIA Company Details
Table 112. IQVIA Business Overview
Table 113. IQVIA Innovative Drug CRO (Contract Research Organisation) Product
Table 114. IQVIA Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 115. IQVIA Recent Development
Table 116. Parexel Company Details
Table 117. Parexel Business Overview
Table 118. Parexel Innovative Drug CRO (Contract Research Organisation) Product
Table 119. Parexel Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 120. Parexel Recent Development
Table 121. Syneos Health Company Details
Table 122. Syneos Health Business Overview
Table 123. Syneos Health Innovative Drug CRO (Contract Research Organisation) Product
Table 124. Syneos Health Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 125. Syneos Health Recent Development
Table 126. MedPace Company Details
Table 127. MedPace Business Overview
Table 128. MedPace Innovative Drug CRO (Contract Research Organisation) Product
Table 129. MedPace Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 130. MedPace Recent Development
Table 131. Wuxi AppTec Company Details
Table 132. Wuxi AppTec Business Overview
Table 133. Wuxi AppTec Innovative Drug CRO (Contract Research Organisation) Product
Table 134. Wuxi AppTec Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 135. Wuxi AppTec Recent Development
Table 136. SUNNOVO Company Details
Table 137. SUNNOVO Business Overview
Table 138. SUNNOVO Innovative Drug CRO (Contract Research Organisation) Product
Table 139. SUNNOVO Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 140. SUNNOVO Recent Development
Table 141. Pharmaron Beijing Company Details
Table 142. Pharmaron Beijing Business Overview
Table 143. Pharmaron Beijing Innovative Drug CRO (Contract Research Organisation) Product
Table 144. Pharmaron Beijing Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 145. Pharmaron Beijing Recent Development
Table 146. Hangzhou Tigermed Consulting Company Details
Table 147. Hangzhou Tigermed Consulting Business Overview
Table 148. Hangzhou Tigermed Consulting Innovative Drug CRO (Contract Research Organisation) Product
Table 149. Hangzhou Tigermed Consulting Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 150. Hangzhou Tigermed Consulting Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Innovative Drug CRO (Contract Research Organisation) Picture
Figure 2. Global Innovative Drug CRO (Contract Research Organisation) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Type: 2024 VS 2031
Figure 4. Clinical CRO Features
Figure 5. Preclinical CRO Features
Figure 6. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. MAH Customer Case Studies
Figure 10. Others Case Studies
Figure 11. Innovative Drug CRO (Contract Research Organisation) Report Years Considered
Figure 12. Global Innovative Drug CRO (Contract Research Organisation) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Innovative Drug CRO (Contract Research Organisation) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region: 2024 VS 2031
Figure 15. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Players in 2024
Figure 16. Global Top Innovative Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CRO (Contract Research Organisation) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Innovative Drug CRO (Contract Research Organisation) Revenue in 2024
Figure 18. North America Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 20. United States Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 24. Germany Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2020-2031)
Figure 32. China Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 40. Mexico Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 44. Turkey Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Charles River Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 48. Labcorp Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 49. Eurofins Scientific Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 50. PPD Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 51. ICON Plc Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 52. Pharmaron Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 53. Inotiv Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 54. ChemPartner Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 55. JOINN Lab Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 56. EVOTEC Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 57. Medicilon Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 58. Crown Bioscience Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 59. Champion Oncology Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 60. IQVIA Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 61. Parexel Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 62. Syneos Health Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 63. MedPace Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 64. Wuxi AppTec Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 65. SUNNOVO Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 66. Pharmaron Beijing Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 67. Hangzhou Tigermed Consulting Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
